BIOTECH ACQUISITION CO-CL A (BIOT) Stock Price, Quote, News and Overview
NASDAQ:BIOT - Nasdaq - KYG1125A1085 - Common Stock - Currency: USD
BIOT Quote, Performance and Key Statistics
10.15
-0.08 (-0.78%)
The current stock price of BIOT is 10.15 USD. In the past month the price increased by 0.5%. In the past year, price increased by 4.1%.
About BIOT
Company Profile
Biotech Acquisition Co. operates as a blank check company. The company is headquartered in New York City, New York. The company went IPO on 2021-01-28. The firm is created for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or other similar business combination with one or more businesses. The firm focuses for a target business in the healthcare sector. The company has no operations and has no revenues.
Company Info
BIOTECH ACQUISITION CO-CL A
545 West 25Th Street, 20Th Floor
New York City NEW YORK 10001 US
CEO: Michael Shleifer
Employees: 0
Phone: 18586920539.0
BIOTECH ACQUISITION CO-CL A / BIOT FAQ
What is the stock price of BIOTECH ACQUISITION CO-CL A today?
The current stock price of BIOT is 10.15 USD. The price decreased by -0.78% in the last trading session.
What is the ticker symbol for BIOTECH ACQUISITION CO-CL A stock?
The exchange symbol of BIOTECH ACQUISITION CO-CL A is BIOT and it is listed on the Nasdaq exchange.
On which exchange is BIOT stock listed?
BIOT stock is listed on the Nasdaq exchange.
What is BIOTECH ACQUISITION CO-CL A worth?
BIOTECH ACQUISITION CO-CL A (BIOT) has a market capitalization of 291.81M USD. This makes BIOT a Micro Cap stock.
How many employees does BIOTECH ACQUISITION CO-CL A have?
BIOTECH ACQUISITION CO-CL A (BIOT) currently has 0 employees.
What are the support and resistance levels for BIOTECH ACQUISITION CO-CL A (BIOT) stock?
BIOTECH ACQUISITION CO-CL A (BIOT) has a support level at 9.86 and a resistance level at 10.18. Check the full technical report for a detailed analysis of BIOT support and resistance levels.
Should I buy BIOTECH ACQUISITION CO-CL A (BIOT) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BIOT, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BIOT, evaluating the profitability, health, valuation and growth aspects
- BIOTECH ACQUISITION CO-CL A (BIOT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BIOTECH ACQUISITION CO-CL A (BIOT) Sales and EPS estimates to see what analysts future expectations are.
- BIOTECH ACQUISITION CO-CL A (BIOT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BIOTECH ACQUISITION CO-CL A (BIOT) Insider and Institutional Ownership to learn about the owners and their transactions.
- BIOTECH ACQUISITION CO-CL A (BIOT) Stock Chart to make your own analysis
- BIOTECH ACQUISITION CO-CL A (BIOT) Latest news and press-releases to stay up to date.
Does BIOTECH ACQUISITION CO-CL A (BIOT) stock pay dividends?
BIOT does not pay a dividend.
What is the Price/Earnings (PE) ratio of BIOTECH ACQUISITION CO-CL A (BIOT)?
The PE ratio for BIOTECH ACQUISITION CO-CL A (BIOT) is 39.04. This is based on the reported non-GAAP earnings per share of 0.26 and the current share price of 10.15 USD. Check the full fundamental report for a full analysis of the valuation metrics for BIOT.
BIOT Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to BIOT. When comparing the yearly performance of all stocks, BIOT is one of the better performing stocks in the market, outperforming 74.39% of all stocks.
BIOT Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to BIOT. BIOT has a bad profitability rating. Also its financial health evaluation is rather negative.
BIOT Financial Highlights
Over the last trailing twelve months BIOT reported a non-GAAP Earnings per Share(EPS) of 0.26. The EPS increased by 1296.12% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | 3.47% | ||
| ROE | 3.68% | ||
| Debt/Equity | 0 |